374
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

The signaling pathway of dopamine D2 receptor (D2R) activation using normal mode analysis (NMA) and the construction of pharmacophore models for D2R ligands

, , , , , & show all
Pages 2040-2048 | Received 18 Mar 2016, Accepted 22 Jun 2016, Published online: 27 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mohammad Wahab Khan & Ayaluru Murali. (2023) Normal mode analysis and comparative study of intrinsic dynamics of alcohol oxidase enzymes from GMC protein family. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-16.
Read now
Kader Sahin, Belma Zengin Kurt, Fatih Sonmez & Serdar Durdagi. (2020) Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays. Journal of Biomolecular Structure and Dynamics 38:11, pages 3342-3358.
Read now
David Montgomery, Alexandra Campbell, Holli-Joi Sullivan & Chun Wu. (2019) Molecular dynamics simulation of biased agonists at the dopamine D2 receptor suggests the mechanism of receptor functional selectivity. Journal of Biomolecular Structure and Dynamics 37:12, pages 3206-3225.
Read now

Articles from other publishers (8)

Agnieszka A. Kaczor, Tomasz M. Wróbel & Damian Bartuzi. (2022) Allosteric Modulators of Dopamine D2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis. Molecules 28:1, pages 178.
Crossref
Theresa Noonan, Katrin Denzinger, Valerij Talagayev, Yu Chen, Kristina Puls, Clemens Alexander Wolf, Sijie Liu, Trung Ngoc Nguyen & Gerhard Wolber. (2022) Mind the Gap—Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence. Pharmaceuticals 15:11, pages 1304.
Crossref
Hung-Jin Huang, Yu-Hsuan Lee, Chu-Lin Chou, Cai-Mei Zheng & Hui-Wen Chiu. (2022) Investigation of potential descriptors of chemical compounds on prevention of nephrotoxicity via QSAR approach. Computational and Structural Biotechnology Journal 20, pages 1876-1884.
Crossref
Patrick Appiah‐Kubi, Fisayo Andrew Olotu & Mahmoud E. S. Soliman. (2019) Probing Binding Landscapes and Molecular Recognition Mechanisms of Atypical Antipsychotic Drugs towards the Selective Targeting of D 2 Dopamine Receptor . Molecular Informatics 38:11-12, pages 1900044.
Crossref
Elumalai Pavadai, Nisha Bhattarai, Prabin Baral, Robert V. Stahelin, Prem P. Chapagain & Bernard S. Gerstman. (2019) Conformational Flexibility of the Protein–Protein Interfaces of the Ebola Virus VP40 Structural Matrix Filament. The Journal of Physical Chemistry B 123:43, pages 9045-9053.
Crossref
Agnieszka A. Kaczor, Justyna Żuk & Dariusz Matosiuk. (2018) Comparative molecular field analysis and molecular dynamics studies of the dopamine D2 receptor antagonists without a protonatable nitrogen atom. Medicinal Chemistry Research 27:4, pages 1149-1166.
Crossref
Ai Jing Li, Wei Xie, Ming Wang & Si Chuan Xu. (2017) Molecular Mechanism and Dynamics of S -Deoxyephedrine Moving through Molecular Channels within D 3 R . ACS Omega 2:12, pages 8896-8910.
Crossref
Ramin Ekhteiari Salmas, Philip Seeman, Busecan Aksoydan, Ismail Erol, Isik Kantarcioglu, Matthias Stein, Mine Yurtsever & Serdar Durdagi. (2017) Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking. ACS Chemical Neuroscience 8:6, pages 1404-1415.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.